236 related articles for article (PubMed ID: 24437490)
1. Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling.
Malaguarnera R; Sacco A; Morcavallo A; Squatrito S; Migliaccio A; Morrione A; Maggiolini M; Belfiore A
Endocrinology; 2014 Apr; 155(4):1207-21. PubMed ID: 24437490
[TBL] [Abstract][Full Text] [Related]
2. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
3. Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells.
Genua M; Pandini G; Sisci D; Castoria G; Maggiolini M; Vigneri R; Belfiore A
Cancer Res; 2009 Sep; 69(18):7270-7. PubMed ID: 19738069
[TBL] [Abstract][Full Text] [Related]
4. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
5. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
6. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits StAR expression in human endometriotic stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation.
Xu JN; Zeng C; Zhou Y; Peng C; Zhou YF; Xue Q
J Clin Endocrinol Metab; 2014 Aug; 99(8):2795-803. PubMed ID: 24823468
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway.
Chen K; Lin ZW; He SM; Wang CQ; Yang JC; Lu Y; Xie XB; Li Q
Biomed Pharmacother; 2019 Jul; 115():108875. PubMed ID: 31028998
[TBL] [Abstract][Full Text] [Related]
9. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells.
Schayek H; Seti H; Greenberg NM; Sun S; Werner H; Plymate SR
Mol Cell Endocrinol; 2010 Jul; 323(2):239-45. PubMed ID: 20417685
[TBL] [Abstract][Full Text] [Related]
11. Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts.
Fahrenholtz CD; Beltran PJ; Burnstein KL
Mol Cancer Ther; 2013 Apr; 12(4):394-404. PubMed ID: 23348048
[TBL] [Abstract][Full Text] [Related]
12. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
Sarfstein R; Friedman Y; Attias-Geva Z; Fishman A; Bruchim I; Werner H
PLoS One; 2013; 8(4):e61537. PubMed ID: 23620761
[TBL] [Abstract][Full Text] [Related]
13. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
[TBL] [Abstract][Full Text] [Related]
14. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome.
Rice S; Elia A; Jawad Z; Pellatt L; Mason HD
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1491-500. PubMed ID: 23846817
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.
Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H
Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.
Nakka M; Agoulnik IU; Weigel NL
Int J Biochem Cell Biol; 2013 Apr; 45(4):763-72. PubMed ID: 23270728
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
19. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
[TBL] [Abstract][Full Text] [Related]
20. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
